Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
markets

1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: Women Grow Presents A 1 Step Guide To Beating 280e: Go Global Starts Now

1 min read • April 16, 2024
Boris Jordan On European Consumer Values On THC Says Not As Prevalent As U.S.; U.S. Slowly Shift From Strategy

1 min read • April 16, 2024
Boris Jordan Says With Acquisition In Canada They Had Business In Australia And New Zealand; Looking At Those Two Markets; Make Curaleaf Brands Most Recognizable In Cannabis Space

1 min read • April 16, 2024
Boris Jordan Says In First Two Weeks Since Removed Cannabis From Narcotic List Seen Five-Fold Increase In Patients Approaching Telemedicine Platforms; Curaleaf Seeing 70% Increase In Order In First Weeks; 50% Increase In Second Week

1 min read • April 16, 2024
Boris Jordan Says For Curafleaf Specifically, There Is European Play; Don’t Have To Wait For Catalyst; Major Catalyst Was German News On Taking Cannabis Off Narcotic List; Seen Bullish Sign In First Two Weeks Coming Off Telemedicine Platforms

1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: Curaleaf Chairman Boris Jordan Says In The U.S. Its Ohio And New York Catlayst And Florida Catalyst And What We Think Will Probably Be Pennsylvania Sometime End Of This Year Or Early Next Year We Might See Catalyst There

1 min read • April 16, 2024
From Benzinga’s Capital Cannabis Conference: Gerald Pascarelli SVP, Equity Research At Wedbush Securities On Diversification Says Having A Brand And Portfolio Cohesiveness Is Very Important ,Says Understanding ROI Is Key And You Need To Protect Your Cash

1 min read • April 16, 2024
From Benzinga’s Capital Cannabis Conference: Adam Stettner CEO FundCanna On Diversification Says If You Try To Overdiversify And Do Too Much Diversification, It Will Not Work

1 min read • April 16, 2024
From Benzinga’s Capital Cannabis Conference: Vahan Ajamian Capital Markets Advisor High Tide On Diversification Says We Are Diversifying Products, But Focusing On The Same Consumer

1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: Dustin Milner CEO Talarya Brands On M&A Says We Don’t See ‘First Mover’ Advantages In Newer Markets, Says There Are Lots of Challenges In Newer Markets, Says We Still See Great Opportunities In California

1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: Emily Paxhia Founding Partner & Managing Partner Poseidon Investment Management On M&A Deals Says There Are Lots Of Challanges In California To Do M&A Deals

1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: Emily Paxhia Founding Partner & Managing Partner Poseidon Investment Management On M&A Deal Says We Are Going To See More M&A Activities In Newer Markets That Are Opening Up
Latest Headlines
View All
6 min read • September 8, 2026
Why Exporting Cannabis to Europe Is Harder Than It Looks: Organigram on EU-GMP, Testing and Supply
10 min read • September 7, 2026
Britain Is Finally Ready to Authorize CBD Foods. Europe Could Rewrite the Rules Again
6 min read • September 7, 2026
How EDUN Grew Vape Sales 519% in Colorado’s Shrinking Cannabis Market
3 min read • September 4, 2026
Fatal Oklahoma Cannabis Blast Intensifies Scrutiny Of State Marijuana Regulation
7 min read • September 4, 2026
Cannabis M&A Enters Its Distressed-Asset Era: What Cresco’s $50 Million Pennsylvania Deal Must Deliver
2 min read • September 3, 2026
Aurora CEO On Curaleaf Takeover: ‘It’s Clear Why They Want It,’ But Offer Isn’t Adequate
6 min read • September 3, 2026
Organigram Says Germany’s Cannabis Market Could Double — Here’s How It Plans to Capitalize
5 min read • September 2, 2026
Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights
10 min read • September 2, 2026
Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround
3 min read • September 2, 2026
Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows
2 min read • September 2, 2026
UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share
7 min read • September 2, 2026
Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis clubs
cannabis cultivation
cannabis earnings
cannabis farms
cannabis study
CBD
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
germany cannabis
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
hemp rules
Hot
IgniteIt Events
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
WNBA
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.
